Oral News and Research

RSS

FDA approves new indication for drug to treat pediatric NDO patients

Today, the U.S. Food and Drug Administration approved a new indication for Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron for extended-release oral suspension) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to neurological impairment, in children ages three years and older.

25 Mar 2021

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

The scientific consensus is that safe and highly effective vaccines are required to end the ongoing pandemic of coronavirus disease 2019 COVID-19, caused by SARS-CoV-2. A new study describes a new vaccine that presents two viral antigens to the human immune system, in order to elicit a more efficacious response.

25 Mar 2021

Researchers find evidence that SARS-CoV-2 infects cells in the mouth

An international team of scientists has found evidence that SARS-CoV-2, the virus that causes COVID-19, infects cells in the mouth.

25 Mar 2021

World-first treatment for oral cancer

Professor Mark McGurk speaks to News-Medical about his groundbreaking research that has led to the discovery of a world-first treatment for oral cancer.

25 Mar 2021

Researchers examine acriflavine's antiviral potential against SARS-CoV-2

Acriflavine is traditionally employed as a topical antiseptic, though has more recently been implicated as an antiviral agent at low doses, potentially by stimulating the production of interferon. In a new study recently uploaded to the bioRxiv* preprint server, the application of the drug to SARS-CoV-2 infection is investigated, demonstrating a broad activity towards a range of other betacoronaviruses.

24 Mar 2021

Study may lead to more refined approaches for head and neck cancers

By targeting an enzyme that plays a key role in head and neck cancer cells, researchers from the UCLA School of Dentistry were able to significantly slow the growth and spread of tumors in mice and enhance the effectiveness of an immunotherapy to which these types of cancers often become resistant.

24 Mar 2021

Research suggests toothpaste and mouthwash ingredients could help prevent SARS-CoV-2 infection

Now, new research published on the bioRxiv preprint server focuses on the effect of some typical ingredients present in commercially available mouthwashes and toothpaste on the mechanisms of SARS-CoV-2 entry into host cells.

24 Mar 2021

Study finds potentially harmful stimulants in supplements containing deterenol

Researchers are urging consumers to avoid using weight loss or sports supplements that list deterenol as an ingredient.

24 Mar 2021

CureVac's COVID-19 vaccine protects mice against emerging SARS-CoV-2 variants

The CVnCoV mRNA vaccine showed neutralizing antibody levels and completely protected mice infected with the B.1.351 variant. No viral genomes were seen in oral swabs, lungs, or brain.

23 Mar 2021

Study examines the impact of dental coverage offered through Michigan’s Medicaid expansion

As the pandemic's economic effects drive more people to enroll in Medicaid as safety-net health insurance, a new study suggests that the program's dental coverage can improve their oral health in ways that help them seek a new job or do better at the one they have.

23 Mar 2021

Dandelion extract inhibits SARS-CoV-2 in vitro

An exciting new study describes a specific inhibitor of the SARS-CoV-2 found in an extract of the common dandelion that could provide a new and fruitful avenue of drug research.

23 Mar 2021

Can SARS-CoV-2 still be transmissible once symptoms have subsided?

Researchers based at the University of Missouri, in partnership with U.S. government science facilities in Maryland, have reported that individuals severely infected with SARS-CoV-2 may be able to continue shedding infectious viral RNA for over three weeks after the symptomatic infection has passed.

22 Mar 2021

Tubeless, wearable insulin pump can improve blood sugar control for people with type 1 diabetes

People with type 1 diabetes can improve their blood sugar control while reducing time with low blood sugar, or hypoglycemia, using Insulet Corporation's Omnipod 5 Automated Insulin Delivery System compared to their standard insulin therapy.

21 Mar 2021

New antibiotic compound can effectively clear multi-drug resistant gonorrhea in animals

A new antibiotic compound clears infection of multi-drug resistant gonorrhea in mice in a single oral dose, according to a new study led by researchers at Penn State and Emory University.

19 Mar 2021

Developing a COVID-19 vaccine using inactivated E. coli

A team of researchers inactivated whole-cell E.coli with a reduced genome and utilized this to express coronavirus-specific fusion peptides, demonstrating a potent anamnestic response.

19 Mar 2021

Researchers explore nanotechnology’s potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

19 Mar 2021

Online learning platform about COVID-19 pandemic aids frontline workers, educates the public

When the COVID-19 pandemic forced medical students out of classrooms and clinical rotations this time last year, the state of Georgia's only public medical school had to quickly rethink its traditional curriculum.

19 Mar 2021

Drinking electrolytes instead of water can help prevent muscle cramps

If you reach for water when a muscle cramp strikes, you might want to think again. New research from Edith Cowan University has revealed drinking electrolytes instead of pure water can help prevent muscle cramps.

18 Mar 2021

New evidence supports ivermectin use in children weighing less than fifteen kilograms

Millions of children weighing less than 15kg are currently denied access to Ivermectin treatment due to insufficient safety data being available to support a change to the current label indication.

18 Mar 2021

KHN’s ‘What the Health?’: ACA packs more benefits — and more confusion

The Covid relief bill signed by President Joe Biden a week ago includes billions of dollars in new health benefits for consumers. But those benefits may be hard for people to take advantage of because of the interaction with the income tax system and the lack of experts to help them navigate the system.

18 Mar 2021

Oral News and Research

FDA approves new indication for drug to treat pediatric NDO patients

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

Researchers find evidence that SARS-CoV-2 infects cells in the mouth

World-first treatment for oral cancer

Researchers examine acriflavine's antiviral potential against SARS-CoV-2

Study may lead to more refined approaches for head and neck cancers

Research suggests toothpaste and mouthwash ingredients could help prevent SARS-CoV-2 infection

Study finds potentially harmful stimulants in supplements containing deterenol

CureVac's COVID-19 vaccine protects mice against emerging SARS-CoV-2 variants

Study examines the impact of dental coverage offered through Michigan’s Medicaid expansion

Dandelion extract inhibits SARS-CoV-2 in vitro

Can SARS-CoV-2 still be transmissible once symptoms have subsided?

Tubeless, wearable insulin pump can improve blood sugar control for people with type 1 diabetes

New antibiotic compound can effectively clear multi-drug resistant gonorrhea in animals

Developing a COVID-19 vaccine using inactivated E. coli

Researchers explore nanotechnology’s potential to deliver synergistic therapeutics for COVID-19

Online learning platform about COVID-19 pandemic aids frontline workers, educates the public

Drinking electrolytes instead of water can help prevent muscle cramps

New evidence supports ivermectin use in children weighing less than fifteen kilograms

KHN’s ‘What the Health?’: ACA packs more benefits — and more confusion

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News